Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Intravenous Albumin on Diastolic Function in Patients with Hepatic Cirrhosis
2005-005083-81Phase 3Active
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Apr 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of albumin (human) in Cirrhosis, sponsored by Hospital Clínic de Barcelona. Primary endpoint: Change in diastolic dysfunction. Started Apr 2006; status: active.
02
Drugs
albumin (human)
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on 2005-005083-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005083-81.